Literature DB >> 17124839

Cartilage oligomeric matrix protein and hyaluronan levels in synovial fluid from horses with osteoarthritis of the tarsometatarsal joint compared to a control population.

S E Taylor1, M P Weaver, A A Pitsillides, B T Wheeler, C P D Wheeler-Jones, D J Shaw, R K W Smith.   

Abstract

REASONS FOR PERFORMING STUDY: Quantification of cartilage oligomeric matrix protein (COMP) levels within synovial fluid from the tarsometatarsal joint has not previously been reported and an effective synovial fluid marker would allow monitoring of disease progression and treatment.
OBJECTIVES: To quantify levels of COMP and hyaluronan (HA) in synovial fluid from the tarsometatarsal joint, identify differences in levels from horses with osteoarthritis (OA) of the tarsometatarsal joint compared to a control population and to correlate levels with radiographic changes in horses with OA.
METHODS: Synovial fluid was collected from the tarsometatarsal joint of 25 horses without hindlimb lameness (controls) and 25 lame horses, subjected to analgesia of the joint. COMP concentrations were measured using a homologous inhibition ELISA. Immunoblots of synovial fluid from 3 lame horses and 3 controls were performed to identify fragmentation of COMP. Hyaluronan (HA) concentration in synovial fluid was determined using a competition ELISA. Radiographs of the lame horses with OA were scored and correlated with levels of COMP and HA.
RESULTS: Concentrations of COMP in OA of the tarsometatarsal joint were significantly lower than in the control samples. An additional fragment band of COMP (approximately 30 kDa) was identified on the immunoblots of the horses with OA and this fragment was not identified in controls. No significant difference was identified in the HA or HA:COMP ratio between lame and control horses. There was no correlation between levels of synovial fluid COMP and HA, and radiographic changes. CONCLUSIONS AND POTENTIAL RELEVANCE: Lowered levels of COMP in synovial fluid of tarsometatarsal joints correlates with the presence of osteoarthritis. However, a single value cannot be used to stage the disease process. Levels of HA may not be a useful marker for this disease. Decreased, rather than increased COMP levels, may reflect significant loss of cartilage in established osteoarthritis. A specific assay for the COMP fragment generated with osteoarthritis may allow the earlier detection of clinical cases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17124839     DOI: 10.2746/042516406x156073

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  6 in total

1.  Pro-inflammatory cytokines and structural biomarkers are effective to categorize osteoarthritis phenotype and progression in Standardbred racehorses over five years of racing career.

Authors:  Andrea Bertuglia; Eleonora Pagliara; Elena Grego; Alessandro Ricci; Nika Brkljaca-Bottegaro
Journal:  BMC Vet Res       Date:  2016-11-08       Impact factor: 2.741

Review 2.  Osteochondritis dissecans (OCD) in Horses - Molecular Background of its Pathogenesis and Perspectives for Progenitor Stem Cell Therapy.

Authors:  Lynda Bourebaba; Michael Röcken; Krzysztof Marycz
Journal:  Stem Cell Rev Rep       Date:  2019-06       Impact factor: 5.739

3.  Ex Vivo Equine Cartilage Explant Osteoarthritis Model: A Metabolomics and Proteomics Study.

Authors:  James R Anderson; Marie M Phelan; Laura Foddy; Peter D Clegg; Mandy J Peffers
Journal:  J Proteome Res       Date:  2020-08-06       Impact factor: 4.466

4.  Proteomic profiling and functional characterization of early and late shoulder osteoarthritis.

Authors:  John Wanner; Roopashree Subbaiah; Yelenna Skomorovska-Prokvolit; Yousef Shishani; Eric Boilard; Sujatha Mohan; Robert Gillespie; Masaru Miyagi; Reuben Gobezie
Journal:  Arthritis Res Ther       Date:  2013-11-06       Impact factor: 5.156

5.  Synovial Fluid Metabolites Differentiate between Septic and Nonseptic Joint Pathologies.

Authors:  James R Anderson; Marie M Phelan; Peter D Clegg; Mandy J Peffers; Luis M Rubio-Martinez
Journal:  J Proteome Res       Date:  2018-07-20       Impact factor: 4.466

6.  Development of a Cartilage Oligomeric Matrix Protein Neo-Epitope Assay for the Detection of Intra-Thecal Tendon Disease.

Authors:  Roger Smith; Patrik Önnerfjord; Kristin Holmgren; Shacko di Grado; Jayesh Dudhia
Journal:  Int J Mol Sci       Date:  2020-03-20       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.